Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage

Inclusion Criteria: * Written informed consent from the patient or legally acceptable representative * Males and females * Diagnose as hypertensive intracerebral hemorrhage * Onset of symptoms within 6\~48 hours * Position of bleeding major in basal ganglia * The sum of scores on items 5 and 6 on the NIHSS were \>= 2 at baseline and the total score (items 1-11) was \>=6 and \<=20 * Volume of Hematoma \<= 30 ml * Premorbid mRS score of 0 or 1 Exclusion Criteria: * Allergy to known study drugs or excipients * Experienced stroke in latest 3 month * Volume of Hematoma \> 5 ml in other bleeding position * Obstructive hydrocephalus * Any diagnosis as other than hypertensive ICH * Unconsciousness * Severe concurrent illness with life expectancy less than 90 days * Pregnancy or breast-feeding